GHK-Cu (Copper Peptide) — 50mg

GHK-Cu (Copper Peptide) — 50mg
Product Specifications
Benefits
Personal responsibility notice: By purchasing this product you confirm that you do so entirely on your own initiative and at your own personal responsibility. You are fully aware of the laws and regulations applicable in your country and region regarding research chemicals.
What is GHK-Cu (Copper Peptide) — 50mg?
GHK-Cu (Glycyl-L-Histidyl-L-Lysine : Copper) is a naturally occurring tripeptide-copper complex found in high concentrations in human plasma, saliva and urine. It was first identified in 1973 by Loren Pickart as a factor that stimulates liver cell repair. Each vial contains 50mg of lyophilized GHK-Cu, ≥99% purity, HPLC tested. GHK-Cu has a broad biological spectrum of action via activation of more than 4,000 genes involved in tissue repair, skin recovery, anti-oxidative protection and anti-inflammatory processes. As a copper chelator GHK-Cu stimulates collagen and elastin synthesis, promotes angiogenesis and wound healing, and has potential hair growth-promoting properties via activation of follicular stem cells. Of all peptides in the catalog GHK-Cu has the most extensive safety data — it is an endogenous peptide with an excellent toxicity profile. GHK-Cu can be administered subcutaneously but is also frequently used as a topical solution for skin recovery and hair health. In research protocols: 1–2mg subcutaneous daily or diluted as a topical solution. For laboratory and research purposes only.
Benefits & Mechanism
PCT & Recovery
Post Cycle Therapy (PCT) is not required after GHK-Cu use.
Frequently Asked Questions (FAQ)
Have questions about this product, ordering, shipping or payment? Visit our dedicated FAQ page for complete answers.
View FAQScientific Research
GHK-Cu was discovered by Loren Pickart in 1973. More than 200 scientific publications available. Genomic studies show activation of more than 4,000 genes. GHK-Cu levels drop from ~200ng/ml at age 20 to ~80ng/ml at age 60. Clinical studies for skin recovery show significant improvement in collagen I production. WADA status: not on the prohibited list.

